12
Participants
Start Date
November 30, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2029
TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
After undergoing a disease specific conditioning regimen (standard of care), participants will receive peripheral blood stem cell transplant from a haploidentical donor or closely matched unrelated donor, depleted of TCR αβ+ and CD19+ cells using the CliniMACS TCR α/β-biotin and CD19 Systems.
CliniMACS® System
The CliniMACS Cell Selection System is based on magnetic-activated cell sorting mechanism. The CliniMACS device is a powerful tool for the isolation of many cell types from heterogeneous cell mixtures.
University of Wisconsin, Madison
OTHER